Racing Toward Efficient AI Workflows - Scorecard - MDSpire

Racing Toward Efficient AI Workflows

At the Focus A-Eye Summit, in the session “Lessons from Formula One: Optimizing Clinical Workflow with AI,” experts examined how artificial intelligence can streamline and accelerate ophthalmic clinical workflows.

  • By

  • Devinder Chauhan, MD, FRCOphth, FRANZCO

  • May 1, 2026

  • 2 min

Share

Clinical Scorecard: Racing Toward Efficient AI Workflows

At a Glance

CategoryDetail
ConditionOphthalmic clinical workflows
Key MechanismsArtificial intelligence integration for decision support and data interoperability
Target PopulationRetina specialists and ophthalmologists
Care SettingClinical ophthalmology

Key Highlights

  • AI can streamline and accelerate clinical workflows in ophthalmology.
  • Decision support software consolidates various data sources for better treatment decisions.
  • Interoperability is crucial for effective data management in clinical settings.
  • Patient engagement outside the clinic improves adherence and clinical outcomes.
  • Barriers to adoption include workflow interruption and software/device compatibility.

Guideline-Based Recommendations

Diagnosis

  • Utilize AI-driven decision support tools for diagnosing macular degeneration.

Management

  • Implement interoperable systems to enhance clinical decision-making.

Monitoring & Follow-up

  • Encourage patient adherence through informed engagement strategies.

Risks

  • Address potential workflow interruptions and complexity in software usage.

Patient & Prescribing Data

Patients with macular degeneration and other retinal conditions

Improved patient outcomes through better-informed treatment adherence.

Clinical Best Practices

  • Adopt AI solutions that integrate seamlessly into existing workflows.
  • Ensure all devices and software communicate effectively to reduce complexity.
  • Engage patients in their treatment process to enhance adherence.

References

    Original Source(s)

    Racing Toward Efficient AI Workflows

    • by Devinder Chauhan, MD, FRCOphth, FRANZCO

    • May 1, 2026

    Related Content

    New Product Applications: Introducing the Cirrus 6000

    Discover how Zeiss's Cirrus 6000 OCT device revolutionizes eye care with faster analysis and enhanced capabilities for disease diagnosis and treatment.

    Peripheral retinal degenerations: multimodal imaging–guided risk stratification and clinical decision-making

    Early Fluid Resolution Predicts Faricimab Durability

    Post hoc analysis suggests rapid retinal fluid resolution may help identify patients with nAMD who can maintain longer faricimab dosing intervals.